August 23, 2012 — German researchers suggest that therapeutic platelet transfusion could become a new standard of care in patients with hematological malignancies who receive autologous stem cell ...
OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...
UCLA Blood and Platelet Center: Bruin Transfusion Stories This post was created by Bruin Media Group, the marketing section of the Daily Bruin. The editorial staff of the Daily Bruin played no role in ...
A preliminary study published in this week's issue of THE LANCET suggests a possible explanation for the biological process responsible for inducing fever and related symptoms after the transfusion of ...
Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...
Background: Transfusion-dependent bone marrow transplant recipients are routinely transfused with ABO group and RhD-compatible blood components. However, because of the scarcity of RhD-negative blood ...
To provide evidence-based guidance on the use of platelet transfusion in people with cancer. This guideline updates and replaces the previous ASCO platelet transfusion guideline published initially in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results